Xin Zeng

Academic / Other · 1 registered clinical trial.

Status	Trial	Phase	Started
Unknown	Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis Decompensated Cirrhosis	N/A	2023-08-18